BernardArthurMasonMD

Oncology • Philadelphia, PA

Physician

Join to view full profile

Dr. Mason is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mason's full profile

Already have an account?

Office
230 W Washington Sq
2nd Floor
Philadelphia, PA 19106
Phone+1 215-829-6088

Fax+1 215-829-6104
Is this information wrong?

Education & Training

Temple University HospitalFellowship, Hematology and Medical Oncology, 1977 - 1978
George Washington UniversityFellowship, Hematology and Medical Oncology, 1976 - 1977
George Washington UniversityResidency, Internal Medicine, 1975 - 1976
University of Pennsylvania Health SystemResidency, Internal Medicine, 1972 - 1975
Perelman School of Medicine at the University of PennsylvaniaClass of 1972

Certifications & Licensure

PA State Medical License 1973 - 2024
NJ State Medical License 1977 - 2009
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer Start of enrollment: 2007 Feb 28
Completed
Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos Start of enrollment: 2011 Jan 01
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma Start of enrollment: 2011 Feb 09
Completed
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.
Joanne F. Rossman, Carla I. Falkson, Ronghui Xu, Coenraad F. Slabber, Bernard A. Mason, Mary F. Mulcahy, Al B. Benson> ;Gastrointestinal Cancer Research. 2011 Jan 1
85 citations
The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high risk breast cancer families
Maurizia Dalla Palma, Susan M. Domchek, Jill Stopfer, Julie Erlichman, Jill D. Siegfried, Jessica Tigges-Cardwell, Bernard A. Mason, Timothy R. Rebbeck, Katherine L. N...> ;Cancer Research. 2008 Sep 1
17 citations
Multicentric glioblastoma multiforme in a patient with BRCA-1 invasive breast cancer.
Sarina B. Elmariah, Jason T. Huse, Bernard A. Mason, Peter D. LeRoux, Robert A. Lustig> ;The Breast Journal. 2006 Sep 1
On the need for biopsy confirmation at suspected first recurrence of cancer.
Mintzer, D.M., Mason, B.A.> ;Am J Clin Oncol. 2003 Apr
25 citations
Breast Cancer in the Very Young Patient: A Multidisciplinary Case Presentation
David M. Mintzer, John R. Glassburn, Bernard A. Mason, Dahlia M. Sataloff> ;The Oncologist. 2002 Dec 1
44 citations
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelos...
Roy A. Beveridge, John A. Miller, Arthur N. Kales, Richard A. Binder, Nicholas J. Robert, Jimmie Harvey, Kevin Windsor, Ira Gore, James Cantrell, Keith A. Thompson, Wi...> ;Cancer Investigation. 1998 Jan 1
12 citations
Erythropoietin permits high-dose chemotherapy with peripheral blood stem-cell transplant for a Jehovah's Witness.
Jason Todd Estrin, Patricia Ford, David H. Henry, Arthur P. Stradden, Bernard A. Mason> ;American Journal of Hematology. 1997 May 1
94 citations
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodg...
Joseph A. Sparano, Peter H. Wiernik, Xiaoping Hu, Catherine Sarta, Edward L. Schwartz, Ruy Soeiro, David H. Henry, Bernard A. Mason, Howard Ratech, Janice P. Dutcher> ;Journal of Clinical Oncology. 1996 Nov 1
277 citations
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology ...
Philip Bonomi, Dianne M. Finkelstein, John C. Ruckdeschel, Ronald H. Blum, M D Green, Bernard A. Mason, Richard G. Hahn, D C Tormey, Jules E. Harris, Robert L. Comis> ;Journal of Clinical Oncology. 1989 Nov 1
Response to Seydel.
Andrew T. Turrisi, Donna J. Glover, Bernard A. Mason> ;International Journal of Radiation Oncology, Biology, Physics. 1988 Sep 1
97 citations
A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer.
Andrew T. Turrisi, Donna J. Glover, Bernard A. Mason> ;International Journal of Radiation Oncology, Biology, Physics. 1988 Jul 1
6 citations
Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for the treatment of limited small cell lung cancer: a preliminary report.
Andrew T. Turrisi, Donna J. Glover, Bernard A. Mason> ;Antibiotics and Chemotherapy. 1988 Jan 1
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
Bonomi PD, Pazdur R, Stolbach L, Mason B, Ettinger D> ;Cancer Treat Rep. 1986-12-01
288 citations
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
John C. Ruckdeschel, Dianne M. Finkelstein, David S. Ettinger, Richard H. Creech, Bernard A. Mason, Rudolf A. Joss, Steven E. Vogl> ;Journal of Clinical Oncology. 1986 Jan 1
93 citations
Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.
John C. Ruckdeschel, Dianne M. Finkelstein, Bernard A. Mason, Richard H. Creech> ;Journal of Clinical Oncology. 1985 Jan 1
Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.
Mason BA, Richter MP, Catalano RB, Creech RB> ;Cancer Treat Rep. 1982-08-01
Effective control of cisplatin-induced nausea using high-dose steroids and droperidol.
Mason BA, Dambra J, Grossman B, Catalano RB> ;Cancer Treat Rep. 1982-02-01
9 citations
Axillary-subclavian vein occlusion in patients with lung neoplasms.
Bernard A. Mason> ;Cancer. 1981 Oct 15
26 citations
Half-body and local chest irradiation as consolidation following response to standard induction chemotherapy for disseminated small cell lung cancer: An Eastern Cooper...
Omar M. Salazar, Richard H. Creech, Philip Rubin, John M. Bennett, Bernard A. Mason, John J. Young, Charles W. Carantino, Robert B. Catalano> ;International Journal of Radiation Oncology, Biology, Physics. 1980 Aug 1
Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small cell lung carcinoma (EST-2575, generation I).
Creech, R. H., Mehta, C. R., Cohen, M., Donavan, M., Sponzo, R., Mason, B. A., Skeel, R. T., Ahmed, F., Creaven, P. J., Lerner, H. J., Foelsch, E.> ;Cancer Treat Rep. 1981 May 01
Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
Sataloff, D. M., Mason, B. A., Prestipino, A. J., Seinige, U. L., Lieber, C. P., Baloch, Z.> ;J Am Coll Surg. 1995 Mar
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Pennsylvania HospitalPhiladelphia, Pennsylvania